Roche Agrees To Grant Tamiflu Manufacturing Rights To 15 Companies
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva and Mylan are among the firms that have agreements with Roche to manufacture generic versions of the flu therapy.
You may also be interested in...
Roche Will Sell Tamiflu Under Tiered Pricing System For Pandemic Use
The firm names Shanghai Pharmaceutical Group as the first sub-licensee of the antiviral oseltamivir.
Roche Will Sell Tamiflu Under Tiered Pricing System For Pandemic Use
The firm names Shanghai Pharmaceutical Group as the first sub-licensee of the antiviral oseltamivir.
Roche To Meet With Generic Firms On Tamiflu Rights After Intervention From Senators
Roche agrees to meet with Teva, Mylan, Ranbaxy and Barr to discuss granting manufacturing rights for Tamiflu in order to meet growing global demand for the avian flu antiviral.